Shares Of Boston Scientific See Volume; Company To Provide Cardiology Business Update At 4:00 PM EDT
Positive Trial Data on Symplicity RDN System Likely to Support MDT Stock
MedLumics New CEO and Board Member Announces 10 Patients Treated in First in Man (FIM) Clinical Trial With the Real-Time Visually Guided AblaView PFA System
Medtronic (MDT) Ascends But Remains Behind Market: Some Facts to Note
Medtronic Announces Long-Term Data From Its SPYRAL HTN-ON MED Clinical Trial That Showed Subjects Who Underwent Radiofrequency Renal Denervation With The Symplicity Spyral Renal Denervation System Had Greater Reductions In 24-Hr ABPM, And OSBP...
Express News | Spyral Htn-on Med Study Shows Significant, Consistent, Long-Term Blood Pressure Lowering Effect at Two Years